Skip to content
Sonic
AI
Sonic
AI
Home
Discover
Ask Sonic
Projects
Use with Claude
Request source or feature
Back
Loading claim details...
Nimbus Therapeutics chose to sell its NASH program to Gilead Sciences over multiple other bidders... — Sonic AI